Cell-based therapies have revealed distinctive therapeutic potential in the field of cancer immunotherapy. Therefore, modifying cells and manipulating their functions to achieve the desired treatment has become a major interest in the field of biomedical research. Here, Creative Biolabs has developed cell surface-based cell-drug conjugates (CDC) that can bring a new generation of cancer treatment products. Unlike conventional cytotoxic drug monotherapy which is considered unsafe and ineffective, our CDC-based cell therapy is designed to specifically target and kill tumor cells while retaining healthy cells. This highly potent cell conjugate possesses limited side effects and provides more precise treatments than chemotherapeutic toxic payloads.
Antibody-Drug Conjugates (ADCs)
To provide best-in-class CDC development services, Creative Biolabs brings together the most renowned cell-drug conjugate experts and long-term experience in cell modification. Don't miss the opportunity to enter the clinic by working with service provider who provides the strongest cell therapy tools on the market!
Cell line preparation and drug procurement
Creative Biolabs provides hundreds of quality-controlled cell lines to advance your research. Currently, we have more than 100 cell lines including cancer cell lines with different disease states, immune cell lines, stem cells from multiple sources, and control cell lines. All of these cell lines have been validated under our strict quality control testing and free from mycoplasma, and undesirable cells and foreign factors.
Available cell lines
Disease State Cells
|Embryonic & Induced Pluripotent Stem Cells
|Bone Marrow Mononuclear Cells (BMMCs)
|Hematopoietic Stem Cells
|Rheumatoid Arthritis and Osteoarthritis Fibroblasts
|Mesenchymal Stem Cells
|Lung Bronchial Epithelial Cells Hepatocytes
|Neural Stem Cells
|Cancer Stem Cells
|Breast Cancer Cells
|Hematopoietic Malignancies Cells
Creative Biolabs can help you source off-the-shelf drug products, or assist you in custom synthesis of drugs of interest. In summary, the drug payload for coupling can be obtained in three ways:
Conjugate antibody to cell surface in minutes
Based on our CellFace™ conjugate technology platform, we utilize fucosyltransferases (Fuc T) to transfer drug to the surface of living cells in minutes. This one-step approach developed by scientist team is a fast, simple, and cost-effective technique for cell surface engineering. Using this method, any durg payload can be introduced to the cell surface without genetic modification of the host cells.
Cell-drug conjugate characterization
Creative Biolabs provides a full set of cell-drug conjugate characterization services including:
CDCs exhibit selective cytotoxicity by precisely targeting only a small subset of cells
We provide a one stop shop to meet all your CDC development needs
Our CDCs are IP-free. You have full ownership of the products which can be translated into the clinic.
All services are only provided for research purposes and Not for clinical use.